UPDATE: Stifel Downgrades Iovanace Biotherapeutics (IOVA) to Hold, Following FDA Feedback, Management Change
Tweet Send to a Friend
(Updated - May 20, 2021 4:48 AM EDT)
Stifel analyst Benjamin Burnett downgraded Iovanace Biotherapeutics (NASDAQ: IOVA) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Benjamin Burnett downgraded Iovanace Biotherapeutics (NASDAQ: IOVA) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
